http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007113687-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d59bf415127c07e766ed71839a73e10f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34c812097f352364f75105b3cf3c5f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c20e3fc0f5a72f7ef08ebc08c2aa29c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d86d1f6a76bee02e41f2423327494711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7482744bdf4cec5e5ffe03bdf759c668
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
filingDate 2007-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f77bf5565a53ad68e0f9e69d8b7bf429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c07c575ba251be5527f2a6c81e8679b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd4a52a3ca8ac90f7567e192168608e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d87c128cc4b996e900a85e4c044ddaf
publicationDate 2008-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007113687-A3
titleOfInvention Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same
abstract The present invention relates to a novel compound of use in the improved delivery of therapeutic drug agents into target cells or tissues, composition comprising the same and uses thereof. The compound is more specifically a conjugate of a peptidic moiety and a camptothecin, a derivative or analog thereof which provides numerous benefits, including enhancement in terms of aqueous solubility, pharmacokinetics and tissue distribution, enlargement of the therapeutic index, and limitation of the inter-patient metabolic variability, as well as improvement of delivery of the biologically active ingredient to the target cells or tissues.
priorityDate 2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03018636-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1512696-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9907414-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004005339-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0202595-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006014712-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005016960-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0001417-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1526183-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24360

Total number of triples: 40.